Sarah B. Doernberg

2.8k total citations
77 papers, 1.1k citations indexed

About

Sarah B. Doernberg is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Sarah B. Doernberg has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 24 papers in Epidemiology and 16 papers in Clinical Biochemistry. Recurrent topics in Sarah B. Doernberg's work include Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Use and Resistance (16 papers) and Bacterial Identification and Susceptibility Testing (16 papers). Sarah B. Doernberg is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (18 papers), Antibiotic Use and Resistance (16 papers) and Bacterial Identification and Susceptibility Testing (16 papers). Sarah B. Doernberg collaborates with scholars based in United States, Australia and Japan. Sarah B. Doernberg's co-authors include Henry F. Chambers, Lisa G. Winston, Kavita K. Trivedi, Vance G. Fowler, Thomas L Holland, Scott Evans, Catherine Liu, Monica Fung, Helen W. Boucher and Vivek Jain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Sarah B. Doernberg

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah B. Doernberg United States	19	378	376	229	216	135	77	1.1k
Rajeshwari Nair United States	17	329 0.9×	508 1.4×	198 0.9×	279 1.3×	77 0.6×	56	1.3k
Sameer Patel United States	16	299 0.8×	229 0.6×	242 1.1×	126 0.6×	71 0.5×	51	849
Clare Rock United States	23	351 0.9×	455 1.2×	310 1.4×	187 0.9×	87 0.6×	92	1.4k
Kaede V. Sullivan United States	17	312 0.8×	326 0.9×	142 0.6×	317 1.5×	50 0.4×	41	892
Karim Khader United States	15	422 1.1×	543 1.4×	244 1.1×	192 0.9×	48 0.4×	52	1.0k
Se Yoon Park South Korea	17	330 0.9×	586 1.6×	150 0.7×	68 0.3×	118 0.9×	102	1.2k
Thana Khawcharoenporn Thailand	20	762 2.0×	712 1.9×	209 0.9×	126 0.6×	168 1.2×	90	1.5k
Ron Hendrix Netherlands	18	275 0.7×	198 0.5×	261 1.1×	196 0.9×	152 1.1×	36	857
Erin Epson United States	12	211 0.6×	535 1.4×	119 0.5×	206 1.0×	55 0.4×	39	1.2k
Michael D. Nailor United States	19	489 1.3×	247 0.7×	191 0.8×	126 0.6×	44 0.3×	62	956

Countries citing papers authored by Sarah B. Doernberg

Since Specialization

Citations

This map shows the geographic impact of Sarah B. Doernberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah B. Doernberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah B. Doernberg more than expected).

Fields of papers citing papers by Sarah B. Doernberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah B. Doernberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah B. Doernberg. The network helps show where Sarah B. Doernberg may publish in the future.

Co-authorship network of co-authors of Sarah B. Doernberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah B. Doernberg. A scholar is included among the top collaborators of Sarah B. Doernberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah B. Doernberg. Sarah B. Doernberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Komarow, Lauren, Yixuan Li, Qiuwen Wu, et al.. (2025). Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial. Trials. 26(1). 500–500.

Norman, Katherine, Emily Lydon, Karen D. Barton, et al.. (2025). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases. 81(Supplement_1). S24–S31.

Minter, Daniel J., Karen D. Barton, Lesley A. Skalla, et al.. (2025). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections. Clinical Infectious Diseases. 81(Supplement_1). S16–S23.

Howard‐Anderson, Jessica, Sarah B. Doernberg, Dennis O. Dixon, et al.. (2025). Interagency Collaboration for Patient-Centered Antibacterial Drug Development. Clinical Infectious Diseases. 81(Supplement_1). S11–S15.

Rubin, Daniel B., Deborah Collyar, Sarah B. Doernberg, et al.. (2024). Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs. Clinical Infectious Diseases. 79(1). 60–69.

Doernberg, Sarah B., et al.. (2024). Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes. Clinical Pharmacology & Therapeutics. 115(4). 847–859. 3 indexed citations

Minter, Daniel J., Ayesha Appa, Henry F. Chambers, & Sarah B. Doernberg. (2024). The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 79(6). 1539–1540.

Komarow, Lauren, et al.. (2024). Impact of rapid antibiotic susceptibility testing for Gram-negative bacteremia varies by pathogen type and resistance: a secondary analysis of the RAPIDS GN trial. Microbiology Spectrum. 13(2). e0178924–e0178924. 1 indexed citations

Minter, Daniel J., Ayesha Appa, Henry F. Chambers, & Sarah B. Doernberg. (2023). Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice. Clinical Infectious Diseases. 77(11). e57–e68. 17 indexed citations

10.

Nelson, George E., Navaneeth Narayanan, Sharon Onguti, et al.. (2023). Principles and Practice of Antimicrobial Stewardship Program Resource Allocation. Infectious Disease Clinics of North America. 37(4). 683–714. 5 indexed citations

11.

Minter, Daniel J., Ayesha Appa, Henry F. Chambers, & Sarah B. Doernberg. (2023). Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice. Clinical Infectious Diseases. 77(11). 1489–1491. 4 indexed citations

12.

Gruenberg, Katherine, et al.. (2023). Inter-rater reliability assessment of antibiotic prescription quality by infectious diseases physicians, fellows, and pharmacists. SHILAP Revista de lepidopterología. 3(1). e227–e227.

13.

Gopinath, Ramya, Daniel B. Rubin, Deborah Collyar, et al.. (2023). Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs. Clinical Infectious Diseases. 77(4). 649–656. 8 indexed citations

14.

Rappold, Ana G., et al.. (2023). Risk of systemic fungal infections after exposure to wildfires: a population-based, retrospective study in California. The Lancet Planetary Health. 7(5). e381–e386. 17 indexed citations

15.

Weng, Yingjie, Di Lu, Jenna Bollyky, et al.. (2021). Race-ethnicity and COVID-19 Vaccination Beliefs and Intentions: A Cross-Sectional Study among the General Population in the San Francisco Bay Area. Vaccines. 9(12). 1406–1406. 4 indexed citations

16.

Trinh, Trang D, Luke Strnad, Lloyd E. Damon, et al.. (2021). Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infection Control and Hospital Epidemiology. 42(9). 1090–1097. 4 indexed citations

17.

Anstey, James, et al.. (2019). Perioperative Use and Safety of Cephalosporin Antibiotics in Patients with Documented Penicillin Allergy. Journal of Allergy and Clinical Immunology. 143(2). AB29–AB29. 3 indexed citations

18.

Doernberg, Sarah B., et al.. (2018). Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single‐center retrospective cohort study and review of the literature. Transplant Infectious Disease. 20(2). e12844–e12844. 51 indexed citations

19.

Baxi, Sanjiv M., Angelo Clemenzi-Allen, Brandon Imp, et al.. (2016). Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy. 60(9). 5276–5284. 16 indexed citations

20.

Doernberg, Sarah B., et al.. (2001). Agonistic behavior in naïve juvenile lobsters depleted of serotonin by 5,7-dihydroxytryptamine. Journal of Comparative Physiology A. 187(2). 91–103. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact